Taro Pharmaceutical Industries Revenue 2010-2023 | TARO

Taro Pharmaceutical Industries revenue from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Taro Pharmaceutical Industries Annual Revenue
(Millions of US $)
2023 $573
2022 $561
2021 $549
2020 $645
2019 $670
2018 $662
2017 $879
2016 $951
2015 $863
2014 $759
2013 $671
2012 $145
2011 $
2011 $108
2010 $
2010 $89
2009 $
Taro Pharmaceutical Industries Quarterly Revenue
(Millions of US $)
2023-12-31 $157
2023-09-30 $148
2023-06-30 $159
2023-03-31 $147
2022-12-31 $139
2022-09-30 $130
2022-06-30 $157
2022-03-31 $143
2021-12-31 $139
2021-09-30 $132
2021-06-30 $147
2021-03-31 $148
2020-12-31 $140
2020-09-30 $143
2020-06-30 $118
2020-03-31 $175
2019-12-31 $148
2019-09-30 $161
2019-06-30 $161
2019-03-31 $180
2018-12-31 $176
2018-09-30 $159
2018-06-30 $155
2018-03-31 $175
2017-12-31 $155
2017-09-30 $170
2017-06-30 $161
2017-03-31 $196
2016-12-31 $220
2016-09-30 $229
2016-06-30 $234
2016-03-31 $265
2015-12-31 $258
2015-09-30 $212
2015-06-30 $215
2015-03-31 $244
2014-12-31 $238
2014-09-30 $251
2014-06-30 $130
2014-03-31 $187
2013-12-31 $214
2013-09-30 $205
2013-06-30 $153
2013-03-31 $165
2012-12-31 $186
2012-09-30 $161
2012-06-30 $159
2012-03-31 $145
2011-12-31 $148
2011-09-30 $138
2011-06-30 $112
2011-03-31 $108
2010-12-31 $102
2010-09-30 $103
2010-06-30 $98
2010-03-31 $89
2009-12-31 $85
2009-09-30 $94
2009-06-30 $97
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.606B $0.629B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.821B 31.64
Chugai Pharmaceutical (CHGCY) Japan $51.488B 23.01
Takeda Pharmaceutical (TAK) Japan $41.459B 8.40
Merck (MKGAF) Germany $24.092B 23.36
Astellas Pharma (ALPMY) Japan $17.210B 27.17
Sandoz Group AG (SDZNY) Switzerland $15.410B 0.00
Neurocrine Biosciences (NBIX) United States $13.631B 37.31
United Therapeutics (UTHR) United States $12.777B 13.62
Shionogi (SGIOY) Japan $11.322B 9.84
Catalent (CTLT) United States $10.041B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.567B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.118B 7.82
Revolution Medicines (RVMD) United States $6.372B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Ionis Pharmaceuticals (IONS) United States $5.933B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.916B 0.00
Summit Therapeutics (SMMT) United States $5.890B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.575B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.209B 0.00
Corcept Therapeutics (CORT) United States $3.016B 27.33
Dyne Therapeutics (DYN) United States $2.890B 0.00
PTC Therapeutics (PTCT) United States $2.747B 0.00
Indivior (INDV) United States $2.279B 10.80
Recursion Pharmaceuticals (RXRX) United States $2.201B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.127B 12.09
Catalyst Pharmaceuticals (CPRX) United States $1.779B 17.31
NewAmsterdam Pharma (NAMS) Netherlands $1.727B 0.00
Evotec AG (EVO) Germany $1.612B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.520B 0.00
Ardelyx (ARDX) United States $1.478B 0.00
Soleno Therapeutics (SLNO) United States $1.417B 0.00
Pacira BioSciences (PCRX) United States $1.309B 12.45
BioCryst Pharmaceuticals (BCRX) United States $1.273B 0.00
Xencor (XNCR) United States $1.269B 0.00
4D Molecular Therapeutics (FDMT) United States $1.222B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.155B 0.00
Collegium Pharmaceutical (COLL) United States $1.039B 6.22
Centessa Pharmaceuticals (CNTA) United Kingdom $1.023B 0.00
Enliven Therapeutics (ELVN) United States $1.021B 0.00
Relay Therapeutics (RLAY) United States $0.970B 0.00
Cassava Sciences (SAVA) United States $0.946B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.913B 14.22
Cronos Group (CRON) Canada $0.909B 0.00
Ocular Therapeutix (OCUL) United States $0.891B 0.00
USANA Health Sciences (USNA) United States $0.857B 14.01
ARS Pharmaceuticals (SPRY) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.806B 0.00
Sage Therapeutics (SAGE) United States $0.722B 0.00
Harrow (HROW) United States $0.636B 0.00
ProKidney (PROK) United States $0.626B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Larimar Therapeutics (LRMR) United States $0.599B 0.00
Silence Therapeutics (SLN) United Kingdom $0.578B 0.00
Lexeo Therapeutics (LXEO) United States $0.573B 0.00
Esperion Therapeutics (ESPR) United States $0.566B 0.00
Savara (SVRA) United States $0.564B 0.00
Heron Therapeutics (HRTX) United States $0.542B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.535B 0.00
KalVista Pharmaceuticals (KALV) United States $0.509B 0.00
Bioventus (BVS) United States $0.505B 19.33
OmniAb (OABI) United States $0.496B 0.00
Siga Technologies (SIGA) United States $0.474B 6.06
Verve Therapeutics (VERV) United States $0.455B 0.00
Tourmaline Bio (TRML) United States $0.435B 0.00
Altimmune (ALT) United States $0.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.412B 0.00
Korro Bio (KRRO) United States $0.386B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.344B 0.00
Black Diamond Therapeutics (BDTX) United States $0.336B 0.00
Organogenesis (ORGO) United States $0.331B 62.38
Xeris Biopharma Holdings (XERS) United States $0.326B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Enanta Pharmaceuticals (ENTA) United States $0.272B 0.00
Fractyl Health (GUTS) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.262B 0.00
Century Therapeutics (IPSC) United States $0.259B 0.00
Aquestive Therapeutics (AQST) United States $0.245B 0.00
ESSA Pharma (EPIX) Canada $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.224B 0.00
Acrivon Therapeutics (ACRV) United States $0.224B 0.00
Foghorn Therapeutics (FHTX) United States $0.224B 0.00
Pyxis Oncology (PYXS) United States $0.223B 0.00
Aldeyra Therapeutics (ALDX) United States $0.222B 0.00
Nanobiotix S.A (NBTX) France $0.217B 0.00
Avita Medical (RCEL) United States $0.216B 0.00
Nektar Therapeutics (NKTR) United States $0.215B 0.00
Prelude Therapeutics (PRLD) United States $0.214B 0.00
Incannex Healthcare (IXHL) Australia $0.211B 0.00
Metagenomi (MGX) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.202B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.195B 0.00
Adherex Technologies (FENC) United States $0.185B 225.33
Elite Pharmaceuticals (ELTP) United States $0.180B 16.84
Achieve Life Sciences (ACHV) Canada $0.168B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Cardiol Therapeutics (CRDL) Canada $0.165B 0.00
Telomir Pharmaceuticals (TELO) United States $0.163B 0.00
Galectin Therapeutics (GALT) United States $0.163B 0.00
Regulus Therapeutics (RGLS) United States $0.158B 0.00
Context Therapeutics (CNTX) United States $0.147B 0.00
MediWound (MDWD) Israel $0.139B 0.00
CytoDyn (CYDY) United States $0.133B 0.00
Conduit Pharmaceuticals (CDT) United States $0.133B 0.00
OptiNose (OPTN) United States $0.131B 0.00
Karyopharm Therapeutics (KPTI) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.112B 7.45
Journey Medical (DERM) United States $0.111B 0.00
FibroGen (FGEN) United States $0.111B 0.00
VAXART, INC (VXRT) United States $0.101B 0.00
Assertio Holdings (ASRT) United States $0.100B 4.57
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Vivani Medical (VANI) United States $0.088B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ProPhase Labs (PRPH) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.09
Champions Oncology (CSBR) United States $0.068B 0.00
Tempest Therapeutics (TPST) United States $0.064B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
BioLineRx (BLRX) Israel $0.053B 0.00
Protara Therapeutics (TARA) United States $0.053B 0.00
DURECT (DRRX) United States $0.051B 0.00
Lipocine (LPCN) United States $0.051B 0.00
Carisma Therapeutics (CARM) United States $0.047B 0.00
Inotiv (NOTV) United States $0.046B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Surrozen (SRZN) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
BioVie (BIVI) United States $0.028B 0.00
Viracta Therapeutics (VIRX) United States $0.026B 0.00
SHINECO (SISI) China $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Unicycive Therapeutics (UNCY) United States $0.024B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Minerva Neurosciences (NERV) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
JanOne (JAN) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.74
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Alaunos Therapeutics (TCRT) United States $0.015B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Plus Therapeutics (PSTV) United States $0.011B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.12